270
Participants
Start Date
October 30, 2017
Primary Completion Date
March 1, 2019
Study Completion Date
July 1, 2019
1% Topical Minocycline Gel
Treating Papulopustular Rosacea while monitoring for safety and efficacy of the active intervention
3% Topical Minocycline Gel
Treating Papulopustular Rosacea while monitoring for safety and efficacy of the active intervention
Topical Vehicle Gel
Treating Papulopustular Rosacea while monitoring for safety and efficacy of the vehicle intervention
Clinical Site - 13, New York
Clinical Site - 2, New York
Clinical Site - 11, Fort Washington
Clinical Site - 10, Norfolk
Clinical Site - 4, High Point
Clinical Site - 5, Tampa
Clinical Site - 8, Goodlettsville
Clinical Site - 14, Clinton Township
Clinical Site - 6, Fridley
Clinical Site - 12, Omaha
Clinical Site - 15, Bryant
Clinical Site - 20, Rogers
Clinical Site - 18, San Antonio
Clinical Site - 3, San Antonio
Clinical Site - 9, San Antonio
Clinical Site - 7, Pflugerville
Clinical Site - 16, Boise
Clinical Site - 19, Santa Monica
Center for Dermatology Clinical Research, Inc., Fremont
Clinical Site - 17, Portland
Clinical Site - 22, Boston
Clinical Site - 23, Watertown
Clinical Site - 21, Berlin
Hovione Scientia Limited
INDUSTRY